A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors

Clinical trial NCT05346484 · TERMINATED

Trial details

NCT number: NCT05346484
Sponsor: Imugene Limited
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Solid Carcinoma Solid Tumor, Adult Metastatic Cancer Advanced Solid Tumor Cholangiocarcinoma Bile Duct Cancer

Start date: 2022-05-17
Primary completion: 2026-01-12
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.